Genethon in the mediaRSS feed
- Read the article : www.mypharma-editions.com
- Read the article : www.santemagasine.fr
After two years of waiting, Genethon BioProd is finally certified as a pharmaceutical manufacturer (JIM.fr)
- Read the article : www.jim.fr
Gene therapies advance, but some see manufacturing challenges
“Gene therapy has traveled a long and winding road to the clinic. The field famously hit a major roadblock 13 years ago when the teenager Jesse Gelsinger suffered a fatal immune reaction in response to a gene therapy product designed to correct his rare liver disease, leading to a perception…”
Author : Elie Dolgin
Non-profit Drugs: a first in France!
Thanks to a new decree, “Drugs for innovative therapy”, Genethon, the AFM-Telethon laboratory, will be able to commercialize products from its research. A first in the non-profit arena.
Author(s) : Handicap.fr – E.Dal’Secco http://www.handicap.fr
Read the article [PDF – 18,7 ko]
“Drugs for innovative therapies”: a new step for AFM-Telethon and its Genethon laboratory.
Read the article [PDF – 21,4 ko]